Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

Cited by (237)

Items 101–200 of 237

1. Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s disease
   Chao Gao, Xin Shen, Yuyan Tan, Shengdi Chen · 2022 · Journal of Neuroinflammation
2. Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene
   Thomas Matthew Lancaster, Alison L. Baird, Claudia Wolf, Margaret C. Jackson, Stephen J. Johnston, Rossen Donev, Johannes Thome, David E.J. Linden · 2011 · European Neuropsychopharmacology
3. Alzheimer’s Disease: Genetic Polymorphisms and Rate of Decline
   Christian Schmidt, Martin Wolff, Nicolas von Ahsen, Inga Zerr · 2012 · Dementia and Geriatric Cognitive Disorders
4. Unveiling Clusters of RNA Transcript Pairs Associated with Markers of Alzheimer’s Disease Progression
   Ahmed Shamsul Arefin, Luke Mathieson, Daniel M. Johnstone, Regina Esther Berretta, Pablo Moscato · 2012 · PLoS ONE
5. Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
   Todd Eliot Golde, Wolfgang J. Streit, Paramita Chakrabarty · 2013 · Alzheimer s Research & Therapy
6. Genetic underpinnings in Alzheimer’s disease – a review
   Ahmed A. Moustafa, Mubashir Hassan, Doaa H. Hewedi, Iman H. Hewedi, Julia K. Garami, Hany Alashwal, Nazar Zaki, Sung‐Yum Seo, Vassilis Cutsuridis, Sergio L. Angulo et al. · 2017 · Reviews in the Neurosciences
7. Alzheimer's disease risk variant in CLU is associated with neural inefficiency in healthy individuals
   Thomas Matthew Lancaster, Lisa M. Brindley, Katherine E. Tansey, Rebecca Sims, Kiran K. Mantripragada, Michael John Owen, Julie H. Williams, David E.J. Linden · 2014 · Alzheimer s & Dementia
8. Genetic Factors Affecting Late-Onset Alzheimer’s Disease Susceptibility
   Maryam Rezazadeh, Aziz Khorrami, Tarlan Yeghaneh, Mahnaz Talebi, Seyed Jalal Kiani, Yaser Heshmati, Jalal Gharesouran · 2015 · NeuroMolecular Medicine
9. Association of GWAS Top Genes With Late-Onset Alzheimer’s Disease in Colombian Population
   Diana Jennifer Moreno, Susana Ruiz, Ángela Magnolia Ríos Gallardo, Francisco Javier Lopera, Henry Ostos, Marc Vía, Gabriel Bedoya · 2017 · American Journal of Alzheimer s Disease & Other Dementias®
10. A Multi-Center Study of ACE and the Risk of Late-Onset Alzheimer's Disease
    Belbin, Olivia, Brown, Kristelle, Shi, Hui, Medway, Christopher, Abraham, Richard, Passmore, Peter, Mann, David, Smith, A. David, Holmes, Clive, McGuinness, Bernadette et al. · 2011 · Journal of Alzheimer's Disease
11. CR1-mediated ATP Release by Human Red Blood Cells Promotes CR1 Clustering and Modulates the Immune Transfer Process
    M. I. Melhorn, Abigail Brodsky, Jessica Estanislau, Joseph A. Khoory, Ben M. W. Illigens, Itaru Hamachi, Yasutaka Kurishita, Andrew D. Fraser, A Nicholson-Weller, Elena V. Dolmatova et al. · 2013 · Journal of Biological Chemistry
12. Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer’s disease
    ARUK Consortium, Kucukkilic, Ezgi, Brookes, Keeley, Barber, Imelda, Guetta-Baranes, Tamar, Morgan, Kevin, Hollox, Edward J. · 2018 · Human Genetics
13. Alzheimer's disease genetics: lessons to improve disease modelling
    Rita João Guerreiro, John Hardy · 2011 · Biochemical Society Transactions
14. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage
    Denise Ferrera, Nadia Mazzaro, Claudio Canale, Laura Gasparini · 2014 · Neurobiology of Aging
15. Impacts of PICALM and CLU variants associated with Alzheimer’s disease on the functional connectivity of the hippocampus in healthy young adults
    Peng Zhang, Wen Qin, Dawei Wang, Bing Liu, Yunting Zhang, Tianzi Jiang, Chunshui Yu · 2014 · Brain Structure and Function
16. Identification of rare variants in Alzheimer’s disease
    Jenny Lord, Alexander J. Lu, Carlos Cruchaga · 2014 · Frontiers in Genetics
17. Genetic variation in Clusterin gene and Alzheimer's disease risk in Han Chinese
    Jin‐Tai Yu, Xiaoying Ma, Yingli Wang, Lei Sun, Lin Tan, Nan Hu, Lan Tan · 2013 · Neurobiology of Aging
18. TOMM40 intron 6 poly‐T length, age at onset, and neuropathology of AD in individuals with APOE ɛ3/ɛ3
    Ge Li, Lynn M. Bekris, Lesley Leong, Ellen J. Steinbart, Jane B. Shofer, Paul K. Crane, Eric Berg Larson, Elaine R. Peskind, Thomas D. Bird, Chang‐En Yu · 2012 · Alzheimer s & Dementia
19. Altered gene expression in late-onset Alzheimer's disease due to SNPs within 3′UTR microRNA response elements
    Jyoti Roy, Bibekanand Mallick · 2017 · Genomics
20. Comparison between amyloid-PET and CSF amyloid-β biomarkers in a clinical cohort with memory deficits
    Caroline Bouter, Jonathan S. Vogelgsang, Jens Wiltfang · 2019 · Clinica Chimica Acta
21. Association study of susceptibility genes for late-onset Alzheimer’s disease in the Japanese population
    Tomoyuki Ohara, Toshiharu Ninomiya, Yoichiro Hirakawa, Kyota Ashikawa, Akira Monji, Yutaka Kiyohara, Shigenobu Kanba, Michiaki Kubo · 2012 · Psychiatric Genetics
22. Innate immunity in Alzheimer’s disease: the relevance of animal models?
    Diana Franco-Bocanegra, James A. R. Nicoll, Delphine Boche · 2017 · Journal of Neural Transmission
23. Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in Alzheimer's disease
    Arpita Ghimire, Sayed Abdur Rehman, Aleena Subhani, Mansoor A. Khan, Ziyaur Rahman, Mohammad Kashif Iqubal, Ashif Iqubal · 2025 · hLife
24. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults
    Guilherme T. Valença, Gyan Prakash Srivastava, Jamary Oliveira Filho, Charles C. White, Lei Yu, Julie A. Schneider, Aron S. Buchman, Joshua M Shulman, David Alan Bennett, Philip L. De Jager · 2016 · PLoS ONE
25. Principles for central nervous system inflammation research: A call for a consortium approach
    Joseph Rogers · 2018 · Alzheimer s & Dementia
26. Alzheimer′s Disease Genes Are Associated with Measures of Cognitive Ageing in the Lothian Birth Cohorts of 1921 and 1936
    Gillian Hamilton, Sarah E. Harris, Gail Davies, David C M Liewald, Albert Tenesa, John M. Starr, David John Porteous, Ian J. Deary · 2011 · International Journal of Alzheimer s Disease
27. CSF biomarkers for Alzheimer’s pathology and the effect size of APOE ɛ4
    Ulf Andréasson, Ronald Lautner, Jonathan M. Schott, Niklas Mattsson, Oskar Hansson, S-K Herukka, Seppo Helisalmi, Michael Ewers, Harald Juergen Hampel, A. Wallin et al. · 2013 · Molecular Psychiatry
28. Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease.
    Samantha L. Rosenthal, Xingbin Wang, F. Yesim Demirci, M. Michael Barmada, Mary Ganguli, Oscar L. López, M. Ilyas Kamboh · 2012 · Europe PMC (PubMed Central)
29. Genetic Evidence for the Involvement of Variants at APOE, BIN1, CR1, and PICALM Loci in Risk of Late-Onset Alzheimer’s Disease and Evaluation for Interactions with APOE Genotypes
    Jalal Gharesouran, Maryam Rezazadeh, Aziz Khorrami, Morteza Ghojazadeh, Mahnaz Talebi · 2014 · Journal of Molecular Neuroscience
30. Potential Peripheral Biomarkers for the Diagnosis of Alzheimer′s Disease
    Seema V. Patel, Raj J. Shah, Paul D. Coleman, Marwan Noel Sabbagh · 2011 · International Journal of Alzheimer s Disease
31. Using CSF biomarkers to replicate genetic associations in Alzheimer's disease
    Jonathan M. Schott · 2011 · Neurobiology of Aging
32. Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
    Matthew J. Huentelman, Matt D. De Both, Wayne M. Jepsen, Ignazio Stefano Piras, Joshua S. Talboom, Mari N. Willeman, Eric M. Reiman, John Hardy, Amanda Myers · 2019 · Scientific Reports
33. Diabetes and Alzheimer's disease: shared genetic susceptibility?
    John Hardy, Bart De Strooper, Valentina Escott‐Price · 2022 · The Lancet Neurology
34. Alzheimer's genetic risk is reduced in primary age‐related tauopathy: a potential model of resistance?
    Corey T. McMillan, Edward B. Lee, Kyra Jefferson‐George, Adam Christian Naj, Vivianna M. Van Deerlin, John Q. Trojanowski, David A. Wolk · 2018 · Annals of Clinical and Translational Neurology
35. Induction of pluripotent stem cells from autopsy donor-derived somatic cells
    Brooke E. Hjelm, Jon B. Rosenberg, Szabolcs Szelinger, Lucia I. Sue, Thomas G. Beach, Matthew J. Huentelman, David Wesley Craig · 2011 · Neuroscience Letters
36. Clathrin, adaptors and disease: Insights from the yeast Saccharomyces cerevisiae
    Gregory S. Payne · 2013 · Frontiers in bioscience
37. Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models
    Michelle Bamji‐Mirza, Yan Li, Dema Najem, Qing Yan Liu, Douglas G. Walker, Lih‐Fen Lue, Jacek Stupak, Kenneth Hoi‐Yiu Chan, Jianjun Li, Mahdi Ghani et al. · 2016 · Journal of Alzheimer s Disease
38. Alzheimer's disease risk factor complement receptor 1 is associated with depression
    Gillian Hamilton, Kathryn Louise Evans, Donald J. MacIntyre, Ian J. Deary, Anna F. Dominiczak, Blair Hamilton Smith, Andrew D. Morris, David John Porteous, Pippa A. Thomson · 2012 · Neuroscience Letters
39. Brain resident microglia in Alzheimer’s disease: foe or friends
    Simranjit Kaur, K. Malleshwari, Anamika Sharma, Vijayasree Vayalanellore Giridharan, Manoj P. Dandekar · 2024 · Inflammopharmacology
40. Fueling the brain - the role of apolipoprotein E in brain energy metabolism and its implications for Alzheimer's disease
    Budny, Vanessa, Ruminot, Iván, Wybitul, Maha, Treyer, Valerie, Barros, L. Felipe, Tackenberg, Christian · 2025 · Translational Psychiatry
41. Multilocus genetic profiling to empower drug trials and predict brain atrophy
    Omid Kohannim A, Xue Hua, Priya Rajagopalan, Derrek P. Hibar, Neda Jahanshad, Joshua D. Grill, Liana G. Apostolova, Arthur W. Toga, Clifford R. Jack, Michael Walter Weiner et al. · 2013 · NeuroImage Clinical
42. High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
    Pedrini, Steve, Chatterjee, Pratishtha, Hone, Eugene, Martins, Ralph N. · 2021 · Journal of Neurochemistry
43. Genetic polymorphisms of clusterin gene are associated with a decreased risk of Alzheimer’s disease
    Yen‐Ling Lin, Shih‐Yuan Chen, Liang‐Chuan Lai, Jen‐Hau Chen, Shi‐Yi Yang, Yi‐Ling Huang, Ta‐Fu Chen, Yu Sun, Li‐Li Wen, Ping‐Keung Yip et al. · 2012 · European Journal of Epidemiology
44. The “LEARn” (Latent Early-Life Associated Regulation) Model: An Epigenetic Pathway Linking Metabolic and Cognitive Disorders
    Debomoy K. Lahiri, Bryan Maloney · 2012 · Journal of Alzheimer s Disease
45. Identification and Confirmation of an Exonic Splicing Enhancer Variation in Exon 5 of the Alzheimer Disease Associated PICALM Gene
    Nathalie C. Schnetz‐Boutaud, Joshua Hoffman, Jared Coe, Deborah G. Murdock, Margaret Ann Pericak‐Vance, Jonathan L. Haines · 2012 · Annals of Human Genetics
46. Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer’s Disease in Caucasian But Not Chinese population
    Zhijie Han, Jiaojiao Qu, Jiehong Zhao, Xiao Zou · 2018 · Scientific Reports
47. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
    Amy R. Nelson · 2022 · Frontiers in Aging Neuroscience
48. The "Alzheimer's disease signature": potential perspectives for novel biomarkers
    Sergio Davinelli, Mariano Intrieri, Claudio Russo, Alfonso Di Costanzo, Davide Zella, Paolo Bosco, Giovanni Scapagnini · 2011 · Immunity & Ageing
49. Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
    Pratip Rana, Edian F. Franco, Yug Rao, Khajamoinuddin Syed, Debmalya Barh, Vasco Azevedo, Rommel Thiago Jucá Ramos, Preetam Ghosh · 2019 · International Journal of Molecular Sciences
50. Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease
    Carmen Antúnez, Merçé Boada, Jesús López‐Arrieta, Concha Moreno‐Rey, Isabel Hernández, Juan Marín, Javier Gayán, Alzheimer’s Disease Neuroimaging Initiative, Antonio González‐Pérez, Luís Miguel Real et al. · 2011 · Alzheimer s & Dementia
51. Impact ofPICALMandCLUon hippocampal degeneration
    Xianfeng Yang, Jin Li, Bing Liu, Yonghui Li, Tianzi Jiang · 2016 · Human Brain Mapping
52. A gene−brain−cognition pathway for the effect of an Alzheimer׳s risk gene on working memory in young adults
    Benson W. Stevens, Amanda Marie DiBattista, George William Rebeck, Adam E. Green · 2014 · Neuropsychologia
53. SUMO modulation of protein aggregation and degradation
    Marco Feligioni, Serena Marcelli, Erin Knock, Urooba Nadeem, Ottavio Arancio, Paul E. Fraser · 2015 · AIMS molecular science
54. Genetic analysis suggests high misassignment rates in clinical Alzheimer's cases and controls
    Escott-Price, Valentina, Baker, Emily, Shoai, Maryam, Leonenko, Ganna, Myers, Amanda J., Huentelman, Matt, Hardy, John · 2019 · Neurobiology of Aging
55. APOE-ε4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology
    Seth D. Talyansky, Yann Le Guen, Nandita M. Kasireddy, Michaël E. Belloy, Michael D. Greicius · 2023 · Acta Neuropathologica Communications
56. Implication of a Genetic Variant at PICALM in Alzheimer's Disease Patients and Centenarians
    Irene Piaceri, Silvia Bagnoli, Ersilia Lucenteforte, Michelangelo Mancuso, Andrea Tedde, Gabriele Siciliano, Silvia Piacentini, Laura Bracco, Sandro Sorbi, Benedetta Nacmias · 2011 · Journal of Alzheimer s Disease
57. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer’s Genetic Risk ( CLU + CR1 + PICALM ) Intensifies Cognitive Aging Genetic Risk ( COMT + BDNF ) Selectively for APOE ɛ 4 Carriers
    Shraddha Sapkota, Roger A. Dixon · 2018 · Journal of Alzheimer s Disease
58. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease
    Chang Kong, Hao Xie, Zhenxing Gao, Ming Shao, Huan Li, Run Shi, Lili Cai, Shanshan Gao, Taolei Sun, Chaoyang Li · 2019 · Virologica Sinica
59. Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug
    Samara J. Vilca, Alexander V. Margetts, Leon Höglund, Isabella Fleites, Lauren L. Bystrom, Tate A. Pollock, Florence Bourgain‐Guglielmetti, Claes Wahlestedt, Luis M. Tuesta · 2024 · Brain Behavior and Immunity
60. Genetic association between clusterin polymorphisms and Alzheimer's disease in a Japanese population
    Miwa Komatsu, Nobuto Shibata, Bolati Kuerban, Tohru Ohnuma, Hajime Baba, Heii Arai · 2011 · Psychogeriatrics
61. Plasma SUMO1 Protein is Elevated in Alzheimer’s Disease
    Sun-Jung Cho, Sang‐Moon Yun, Dae-Hoon Lee, Chulman Jo, Moon Ho Park, Changsu Han, Young Ho Koh · 2015 · Journal of Alzheimer s Disease
62. Clusterin (APOJ) in Alzheimer’s Disease: An Old Molecule with a New Role
    Sarah K. Woody, Liqin Zhao · 2016 · InTech eBooks
63. Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis
    Mercer, Jacob L., Argus, Joseph P., Crabtree, Donna M., Keenan, Melissa M., Wilks, Moses Q., Chi, Jen-Tsan Ashley, Bensinger, Steven J., Lavau, Catherine P., Wechsler, Daniel S. · 2015 · PLOS ONE
64. Psychotropic Drug Effects on Gene Transcriptomics Relevant to Alzheimer Disease
    Edward C. Lauterbach · 2011 · Alzheimer Disease & Associated Disorders
65. Crry silencing alleviates Alzheimer’s disease injury by regulating neuroinflammatory cytokines and the complement system
    Xi‐Chen Zhu, Tao Ma, Lu Liu, Wen-Zhuo Dai · 2021 · Neural Regeneration Research
66. The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum
    Wei Xu, Hui-Fu Wang, Lin Tan, Meng‐Shan Tan, Chen-Chen Tan, Xi‐Chen Zhu, Dan Miao, Wan-Jiang Yu, Teng Jiang, Lan Tan et al. · 2016 · Scientific Reports
67. A novel mouse model expressing human forms for complement receptors CR1 and CR2
    Harriet M. Jackson, Kate E. Foley, Rita O’Rourke, Timothy M. Stearns, Dina Fathalla, B. Paul Morgan, Gareth R. Howell · 2020 · BMC Genetics
68. Amyloid β peptide promotes lysosomal degradation of clusterin via sortilin in hippocampal primary neurons
    Yunling Wang, Xike Qin, Hemant K. Paudel · 2017 · Neurobiology of Disease
69. Comorbidity Genes of Alzheimer’s Disease and Type 2 Diabetes Associated with Memory and Cognitive Function
    Seong Beom Cho · 2024 · International Journal of Molecular Sciences
70. Angiotensin-converting enzyme polymorphisms AND Alzheimer’s disease susceptibility: An updated meta-analysis
    Xiaoyu Xin, Ze-Hua Lai, Kai-qi Ding, Lili Zeng, Jianfang Ma · 2021 · PLoS ONE
71. Neuroimaging genetic risk for Alzheimer’s disease in preclinical individuals: from candidate genes to polygenic approaches
    Harrison, Theresa M., Bookheimer, Susan Y. · 2016 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
72. An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer’s disease
    Giorgio Dolci, Federica Cruciani, Md Abdur Rahaman, Anees Abrol, Jiayu Chen, Zening Fu, Ilaria Boscolo Galazzo, Gloria Menegaz, Vince D. Calhoun, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Journal of Neural Engineering
73. Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide
    Amy R. Nelson, Abhay P. Sagare, Berislav V. Zloković · 2016 · Elsevier eBooks
74. The Interactive Effects of Age and PICALM rs541458 Polymorphism on Cognitive Performance, Brain Structure, and Function in Non-demented Elderly
    Zhen Liu, Xiangwei Dai, Junying Zhang, Xin Li, Yaojing Chen, Chao Ma, Kewei Chen, Dantao Peng, Zhanjun Zhang · 2017 · Molecular Neurobiology
75. The influence of 17q21.31 and APOE genetic ancestry on neurodegenerative disease risk
    Nadia V. Harerimana, Alison Goate, Kathryn R. Bowles · 2022 · Frontiers in Aging Neuroscience
76. Informative combination of CLU rs11136000, serum HDL levels, diabetes, and age as a new piece of puzzle-picture of predictive medicine for cognitive disorders
    Mohsen Aghajanpour-Mir, Fatemeh Amjadi‐Moheb, Tahereh Dadkhah, Seyed Reza Hosseini, Elham Ghadami, Ehsan Assadollahi, Haleh Akhavan‐Niaki, Alijan Ahmadi Ahangar · 2018 · Molecular Biology Reports
77. Investigating Statistical Epistasis in Complex Disorders
    James C. Turton, James M. Bullock, Christopher Medway, Hui Shi, Kristelle S. Brown, Olivia Belbin, Noor A Kalsheker, Minerva M. Carrasquillo, Dennis W. Dickson, Neill R. Graff‐Radford et al. · 2011 · Journal of Alzheimer s Disease
78. Genetic Burden for Late-Life Neurodegenerative Disease and Its Association With Early-Life Lipids, Brain, Behavior, and Cognition
    Sander Lamballais, Ryan L. Muetzel, M. Arfan Ikram, Henning W. Tiemeier, Meike Willemijn Vernooij, Tonya J.H. White, Hieab H.H. Adams · 2020 · Frontiers in Psychiatry
79. Complement receptor 1 genetic polymorphism contributes to sporadic Alzheimer’s disease susceptibility in Caucasians: a meta-analysis
    Hai Dan Yuan, Lingling Du, Pingping Ge · 2020 · Bioscience Reports
80. AP180 N-Terminal Homology (ANTH) and Epsin N-Terminal Homology (ENTH) Domains: Physiological Functions and Involvement in Disease
    Sho Takatori, Taisuke Tomita · 2018 · Advances in experimental medicine and biology
81. Impacts of AD-Related ABCA7 and CLU Variants on Default Mode Network Connectivity in Healthy Middle-Age Adults
    Xin Yuan Zhang, Yun Fei Wang, Li Juan Zheng, Han Zhang, Li Lin, Guangming Lu, Long Jiang Zhang · 2020 · Frontiers in Molecular Neuroscience
82. Ubiquitination and SUMOylation of Amyloid and Amyloid-like Proteins in Health and Disease
    Lenzie K. Ford, Luana Fioriti, Eric R. Kandel · 2019 · Current Issues in Molecular Biology
83. Association of CLU and TLR2 gene polymorphisms with late-onsetAlzheimer disease in a northwestern Iranian population
    Nasim Sohrabifar, Jalal Gharesouran, Mahnaz Talebi, Morteza Ghojazadeh, Seiied Mojtaba Mohaddes Ardebili · 2015 · TURKISH JOURNAL OF MEDICAL SCIENCES
84. Epigenetic processes in Alzheimer's disease
    Isabel Castanho, Katie Lunnon · 2019 · Elsevier eBooks
85. Angiotensin-converting enzyme gene polymorphisms and risk for sporadic Alzheimer’s disease: a meta-analysis
    Xuebin Wang, Ning‐hua Cui, Jia-Jia Gao, Xueping Qiu, Na Yang, Fang Zheng · 2014 · Journal of Neural Transmission
86. On Estimation of Genome Composition in Genetically Admixed Individuals Using Constrained Genomic Regression
    Vinzent Boerner, Dörte Wittenburg · 2018 · Frontiers in Genetics
87. Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease
    Suk Ling Ma, LINDA C. W. LAM · 2011 · Clinical Psychopharmacology and Neuroscience
88. Biological Basis for Sleep Disturbance and Behavioral Symptoms in Dementia: A Biobehavioral Model
    Diana Lynn Woods, Linda R. Phillips, Jennifer L. Martin · 2011 · Research in Gerontological Nursing
89. A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer’s Disease
    Wenjia Wang, Jonas Mandel, Jan Bouaziz, Daniel Commenges, Serguei Nabirotchkine, Ilya M. Chumakov, Daniel Cohen, Mickaël Guedj, the Alzheimer’s Disease Neuroimaging Initiative · 2015 · PLoS ONE
90. Lack of Association of thePICALMrs3851179 Polymorphism With Parkinson's Disease in the Greek Population
    Kallirhoe Kalinderi, Sevasti Bostantjopoulou, Zoe Katsarou, Jordi Clarimón, Liana Fidani · 2012 · International Journal of Neuroscience
91. APOE genotype-dependent differences in human astrocytic energy metabolism
    Budny, Vanessa, Bodenmann, Chantal, Zürcher, Kathrin J., Krüger, Maik, de Leeuw, Sherida M., Weber, Rebecca Z., Rust, Ruslan, Ravotto, Luca, Ruminot, Iván, Barros, L. Felipe et al. · 2025 · Frontiers in Cellular Neuroscience
92. Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer’s disease in a European population
    Emily Simmonds, Ganna Leonenko, Ümran Yaman, Eftychia Bellou, Amanda Myers, Kevin Morgan, Keeley J. Brookes, John Hardy, Dervis A. M. Salih, Valentina Escott‐Price · 2024 · Translational Psychiatry
93. Polymorphism rs11867353 of Tyrosine Kinase Non-Receptor 1 (TNK1) Gene Is a Novel Genetic Marker for Alzheimer’s Disease
    Tomáš Zeman, Vladimír J. Balcar, Kamila Cahová, Jana Janoutová, Vladimí­r Janout, Jan Lochman, Omar Šerý · 2020 · Molecular Neurobiology
94. Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus
    Gillian Hamilton, Richard Killick, Jean‐Charles Lambert, Philippe Amouyel, Minerva M. Carrasquillo, V. Shane Pankratz, Neill R. Graff‐Radford, Dennis W. Dickson, Ronald Carl Petersen, Steven G. Younkin et al. · 2012 · Neurobiology of Aging
95. Primer in Genetics and Genomics, Article 7—Multifactorial Concepts: Gene–Gene Interactions
    Ansley Grimes Stanfill, Athena Starlard‐Davenport · 2018 · Biological Research For Nursing
96. Astrocyte-microglia interaction in the expression of a pro-inflammatory or pain-related phenotype: molecular and cellular aspects
    Massimo Barbierato · 2012 · Padua Research Archive (University of Padova)
97. Correction: Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
    Lesley Jones, Peter Holmans, Marian L. Hamshere, Denise H. Harold, Valentina Moskvina, Dobril K. Ivanov, Andrew J. Pocklington, Richard Abraham, Paul Hollingworth, Rebecca Sims et al. · 2011 · PLoS ONE
98. Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.
    Weidong Ji, Lanling Xu, Haiyun Zhou, Suishan Wang, Yan Fang · 2015 · PubMed Central
99. Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease
    Sergio Branciamore, Grigoriy Gogoshin, Andréi S. Rodin, Amanda Myers · 2024 · Scientific Reports
100. The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
     Ezequiel Serrano, Pablo G. Sanz, Francisco José Barrantes · 2021 · Springer eBooks